Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

After the 20th week of pregnancy, either new-onset high blood pressure or worsening of existing high blood pressure accompanied by protein in the urine is defined as preeclampsia. Before 20 weeks ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

Merck's diversified pipeline includes promising oncology candidates and a new pneumococcal vaccine, but lacks a ready-made Keytruda replacement. Investors should monitor R&D updates closely ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

The buyout tails Merck's larger M&A move last year, when it bought Prometheus Biosciences and its late-stage bowel disease antibody for $10.8 billion. The New Jersey-based pharma followed that up ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to ...

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...

Our meteorologists are ready. Sign up for the NBC 6 Weather newsletter to get the latest forecast in your inbox. Merck also lowered its adjusted profit guidance to a range of $7.72 to $7.77 per ...

Merck’s attempts to establish islatravir as the backbone of a new generation of HIV therapies hit trouble in 2021 when falls in total lymphocyte and CD4+ T-cell counts led the drugmaker to pause ...

The company benefited from rapid international launches. Merck’s new pneumococcal vaccine, CAPVAXIVE, received FDA approval and an ACIP recommendation, while its acquisition of EyeBio marks a ...